After 1 month, in the period of chronic ischemic left ventricular dysfunction, the pMSC-MiCi-HIF-1α were implanted into the border zone of infarction via electromagnetic guidance of NOGA percutaneous intra-myocardial biologics delivery system, as described previously (Gyöngyösi and Dib 2011; Pavo et al., 2014b). The gene discussed is HIF1A; the disease is infarction.